|
| 37812782 | Occupational Benzene Exposure and Lung Cancer Risk: A Pooled Analysis of 14 Case-Control Studies. | Am J Respir Crit Care Med | 2024 |
| 37487906 | Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027 From the International Association for the Study of Lung Cancer. | J Thorac Oncol | 2024 |
| 38055287 | Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls. | Cancer | 2024 |
| 36054442 | Occupational exposure to nickel and hexavalent chromium and the risk of lung cancer in a pooled analysis of case-control studies (SYNERGY). | Int J Cancer | 2023 |
| 37633678 | Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies. | Lancet Public Health | 2023 |
| 37738239 | Large-scale whole exome sequencing studies identify two genes,CTSL and APOE, associated with lung cancer. | PLoS Genet | 2023 |
| 37150255 | Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis. | J Thorac Oncol | 2023 |
| 37379654 | Plasma protein biomarkers for early prediction of lung cancer. | EBioMedicine | 2023 |
| 37142382 | Defining the road map to a UK national lung cancer screening programme. | Lancet Oncol | 2023 |
| 37236969 | Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population. | Nat Commun | 2023 |
| 37369027 | Circulating proteome for pulmonary nodule malignancy. | J Natl Cancer Inst | 2023 |
| 37471639 | Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk. | Hum Mol Genet | 2023 |
| 36404465 | Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program. | Ann Epidemiol | 2023 |
| 36307040 | Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study. | J Thorac Oncol | 2023 |
| 34716280 | Selection of eligible participants for screening for lung cancer using primary care data. | Thorax | 2022 |
| 35437574 | Occupational Exposure to Polycyclic Aromatic Hydrocarbons and Lung Cancer Risk: Results from a Pooled Analysis of Case-Control Studies (SYNERGY). | Cancer Epidemiol Biomarkers Prev | 2022 |
| 35500836 | A Large-Scale Genome-Wide Gene-Gene Interaction Study of Lung Cancer Susceptibility in Europeans With a Trans-Ethnic Validation in Asians. | J Thorac Oncol | 2022 |
| 35514094 | Attitudes towards the integration of smoking cessation into lung cancer screening in the United Kingdom: A qualitative study of individuals eligible to attend. | Health Expect | 2022 |
| 35915169 | Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer. | Nat Genet | 2022 |
| 35101137 | Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer. | Eur J Med Res | 2022 |
| 35027437 | Accounting for EGFR Mutations in Epidemiologic Analyses of Non-Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 35138370 | Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk. | Hum Mol Genet | 2022 |
| 34864164 | Lung Cancer Screening Considerations During Respiratory Infection Outbreaks, Epidemics or Pandemics: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report. | J Thorac Oncol | 2022 |
| 34815255 | Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors. | Cancer Res | 2022 |
| 32924180 | Integration of multiomic annotation data to prioritize and characterize inflammation and immune-related risk variants in squamous cell lung cancer. | Genet Epidemiol | 2021 |
| 33594163 | Rare deleterious germline variants and risk of lung cancer. | NPJ Precis Oncol | 2021 |
| 33667223 | Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers. | PLoS Genet | 2021 |
| 33726925 | A reply to "Lung cancer outcomes: Are BMI and race clinically relevant?" | Lung Cancer | 2021 |
| 34950920 | Understanding the lung cancer mortality reductions produced by low-dose CT screening-Authors' reply. | Lancet Reg Health Eur | 2021 |
| 34583222 | Analysis of the baseline performance of five UK lung cancer screening programmes. | Lung Cancer | 2021 |
| 34806061 | Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis. | Lancet Reg Health Eur | 2021 |
| 34389358 | Paving the way for application of next generation risk assessment to safety decision-making for cosmetic ingredients. | Regul Toxicol Pharmacol | 2021 |
| 33942106 | Application of two job indices for general occupational demands in a pooled analysis of case-control studies on lung cancer. | Scand J Work Environ Health | 2021 |
| 34002017 | A multi-omics study links TNS3 and SEPT7 to long-term former smoking NSCLC survival. | NPJ Precis Oncol | 2021 |
| 33082166 | Liverpool Lung Project lung cancer risk stratification model: calibration and prospective validation. | Thorax | 2021 |
| 33046839 | Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives. | Nat Rev Clin Oncol | 2021 |
| 33472890 | Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model. | Cancer Res | 2021 |
| 32889700 | Comprehensive functional annotation of susceptibility variants identifies genetic heterogeneity between lung adenocarcinoma and squamous cell carcinoma. | Front Med | 2021 |
| 32914876 | Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization. | Int J Cancer | 2021 |
| 31577861 | Genome-wide association study of INDELs identified four novel susceptibility loci associated with lung cancer risk. | Int J Cancer | 2020 |
| 33491742 | Development and validation of a multivariable risk prediction model for head and neck cancer using the UK Biobank. | Int J Oncol | 2020 |
| 31995680 | Mortality Reduction with Low-Dose CT Screening for Lung Cancer. | N Engl J Med | 2020 |
| 32027538 | The International Association for the Study of Lung Cancer Early Lung Imaging Confederation. | JCO Clin Cancer Inform | 2020 |
| 31696517 | Transcriptome-wide association study reveals candidate causal genes for lung cancer. | Int J Cancer | 2020 |
| 32020063 | Long non-coding RNA dysregulation is a frequent event in non-small cell lung carcinoma pathogenesis. | Br J Cancer | 2020 |
| 31690469 | Erratum to "Evaluation of a health service adopting proactive approach to reduce high risk of lung cancer: The Liverpool Healthy Lung Programme" [Lung Cancer 134 (August) (2019) 66-71]. | Lung Cancer | 2020 |
| 32599792 | Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe. | Cancers (Basel) | 2020 |
| 32699080 | Genetic Determinants of Lung Cancer Prognosis in Never Smokers: A Pooled Analysis in the International Lung Cancer Consortium. | Cancer Epidemiol Biomarkers Prev | 2020 |
| 32393777 | Protein-altering germline mutations implicate novel genes related to lung cancer development. | Nat Commun | 2020 |
| 32420066 | Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort. | Transl Lung Cancer Res | 2020 |